An interventional study of Commercially available Receiver in the Canal (RIC) hearing devices and Hearing Aids plus Remote Microphone System in Hearing Loss, Bilateral Sensorineural, sponsored by Sonova AG. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 95 Years. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by Sonova AG · Not applicable, Interventional, and Treatment
This study will compare speech understanding in noise using a remote microphone with hearing aids and compatible receivers with speech understanding in noise using hearing aids alone in a population of hearing impaired adults, age 18 and over. Participants will be tested in a near condition (target speech and remote microphone located 1 meter away from participant) as well as a far condition (target speech and remote microphone located 2 meters away from participant). Subjective questionnaire about listening effort and overall satisfaction will also be administered to each participant.
796 studies on the registry are indexed under Hearing Loss; 193 are open to participants now.
This study's planned enrollment of 20 is below the median of 44 across 561 interventional studies indexed under Hearing Loss.
Browse Hearing Loss studies →Sonova AG is the lead sponsor of 89 studies on the registry; 6 are open to participants now.
Of its 27 completed or terminated interventional studies of FDA-regulated products, 19 (70%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
18-95 years of age
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants who complete speech testing with the hearing aids plus the remote microphone system first, and then complete speech testing with HAs alone
Device: Commercially available Receiver in the Canal (RIC) hearing devices · Device: Hearing Aids plus Remote Microphone System
Participants who complete speech testing with hearing aids alone first, then complete speech testing with HAs plus remote microphone system
Device: Commercially available Receiver in the Canal (RIC) hearing devices · Device: Hearing Aids plus Remote Microphone System
Commercially available hearing aids that are the RIC form factor
Commercially available hearing aids in the RIC form factor plus the Remote Microphone system, which includes an embedded receiver in the hearing aids and a wireless remote microphone transmitter.
Speech Understanding in Noise Performance
A validated test of speech understanding in which a sentence is presented from a loud-speaker 1-2 meters away from participant, while competing background noise is presented from four corner loud-speakers. The participant repeats as many words as they understand and a percentage correct is calculated for number correct out of total words presented. A higher score is better.
Time frame: One day lab visit- participants will be tested during a 2 hour lab visit with no subsequent visits planned
Subjective Feedback
Subjects will be asked for their feedback using a subjective questionnaire with questions on overall satisfaction of sound quality, listening effort, and noise intrusiveness. Questions will be presented as a scale to compare experience with and without the remote microphone system.
Time frame: One day lab visit- participants will be tested during a 2 hour lab visit with no subsequent visits planned
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2026 (actual). Primary completion is estimated for Nov 2026, 1 month after the start.
Of 125 industry-sponsored interventional studies with no phase under Hearing Loss, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 15. This study's planned 1 month is below that.
Counting every sponsor, half of 321 studies reached it within 19 months; a quarter within 5 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.